- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Biota Pharmaceuticals Inc+ Add to Watchlist
NB1:GR2.904 EUR 0.103 3.68%
As of 03:07:13 ET on 12/20/2013.
Company Profile for Biota Pharmaceuticals Inc (NB1)
Biota Pharmaceuticals Inc is an anti-infective drug development company with expertise in respiratory diseases, particularly influenza. The Company developed the first neuraminidase inhibitor. Biota's research breakthroughs include a series of candidate drugs aimed at treatment of respiratory syncytial virus (RSV) disease and Hepatitis C (HCV) virus infections.
Biota Pharmaceuticals Inc
Key Executives for Biota Pharmaceuticals Inc (NB1)
|Russell H PlumbPresident/CEO||Peter AzzarelloChief Accounting Officer|
|Joseph M PattiExec VP:Development & Strategy|